IQVIA Holdings Inc.
HealthcareNYSE:IQV · New York Stock Exchange
-$1.75 today
Vol 0.68M · Avg 1.62M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
20.9%
avg 1.3%
ROIC
8.2%
avg 6.5%
ROA
4.5%
avg 3.8%
Analysis
ROE is currently the strongest return metric at 20.9% versus its period average of 1.3%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Ari Bousbib | Chief Executive Officer & Chairman | $7.16M | — | 65 | $78,264.00 | 0.05% |
Michael J. Fedock | Executive Vice President & Chief Financial Officer | $2.21M | — | 50 | $9,472.00 | <0.01% |
W. Richard Staub | President of Research & Development Solutions | $1.83M | — | 63 | $26,088.00 | 0.02% |
Alistair Grenfell | President of Commercial Solutions | $1.70M | — | 52 | $26,088.00 | 0.02% |
Eric Sherbet | Executive Vice President, General Counsel & Secretary | $1.50M | — | 62 | $12,112.00 | <0.01% |
Duane Sachs | Senior Vice President of Corporate Development | — | — | — | — | — |
Jeffrey A. Spaeder | Chief Medical & Scientific Officer | — | — | — | — | — |
Kerri Joseph | Senior VP of Investor Relations & Treasurer | — | — | — | — | — |
James G. Berkshire | Executive Vice President of Global Infrastructure & Operations | — | — | 52 | $11,180.00 | <0.01% |
Keriann Cherofsky | Senior Vice President, Corporate Controller & Chief Accounting Officer | — | — | 41 | $2,795.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
10
$22.68M
Net Sentiment
$22.68M
Net selling
Most Active
BOUSBIB ARI
7 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 10 sells worth $22.68M over the last 12 months. That adds up to net selling of $22.68M. BOUSBIB ARI was the most active insider with 7 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +30.4% | +13.1% (15yr)6 analysts |
| Revenue | N/A | N/A | +5.6% | +9.2% (15yr)13 analysts |
| Net Income | N/A | N/A | +29.7% | +15.6% (15yr)13 analysts |
| EBIT | N/A | N/A | +17.7% | +10.4% (15yr)13 analysts |
Analysis
Recent growth has been strongest in EPS at +30.4% over three years. Forward estimates point to Net Income at +15.6% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Cardinal Health, Inc.
NYSE:CAH
$52.47B
Humana Inc.
NYSE:HUM
$45.38B
Haleon plc
NYSE:HLN
$40.33B
Agilent Technologies, Inc.
NYSE:A
$36.61B
Alcon Inc.
NYSE:ALC
$32.54B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.54B
ResMed Inc.
NYSE:RMD
$28.09B
Illumina, Inc.
NASDAQ:ILMN
$24.37B
Waters Corporation
NYSE:WAT
$23.17B
Mettler-Toledo International Inc.
NYSE:MTD
$22.86B
Who manages IQV?
IQVIA Holdings Inc. (IQV) lists 10 active executives. The top listed executive is Ari Bousbib, Chief Executive Officer & Chairman.
Are IQV insiders buying or selling?
Recent insider activity shows net selling of $7.69M.
Explore More
Continue the stock analysis
Jump to another research area for this company.